Use of antidepressants during pregnancy does not affect child development, according to a prospective study published in the American Journal of Psychiatry.
Researchers compared mother?child pairs who were exposed to tricyclic antidepres-sants (n = 46) or fluoxetine (n = 40) during gestation with an unexposed, nonde-pressed control group (n = 36). Neither tricyclic antidepressants nor fluoxetine affected the child?s global IQ, language development, or behavior.
Instead, the mothers? depression was associated with impaired cognitive and language achievement among their children.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs